In humans, polymorphic variants at the ADCY3 locus are associated with increased BMI and fat mass [30], while carriers of loss-of-function alleles present with obesity, insulin resistance, dyslipidemia, and T2D. Here, ADCY3 is linked to metabolic syndrome.